Difesa Capital Management’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATIP.WS
Difesa Capital Management's ATIP.WS Position: Q2 2023 in Review
Difesa Capital Management sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q2 2023, closing a stake of 18,918 shares — an estimated $496 sold.
Difesa Capital Management first reported a position in ATIP.WS in Q1 2022 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATIP.WS as of Q2 2023.
- Difesa Capital Management reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
- Difesa Capital Management sold 18,918 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $496.
- Difesa Capital Management first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q1 2022 and held it in 5 quarters.
- Difesa Capital Management's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $5K in Q1 2022.
- 1 fund tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2023.
Based on Difesa Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.